Q2054 Lisocabtagene mara car pos t
Q-Codes
Also known as: Jcar017, lisocabtagene maraleucel, CAR-T
Lisocabtagene maraleucel CAR-T cell immunotherapy for CD19-positive B-cell lymphomas.
Clinical Context
Used for relapsed/refractory large B-cell lymphoma. Engineered CAR-T cells target CD19+ cells. Requires inpatient monitoring for immune effects.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.